Tag: Sun Pharma

Osteoarthritis Candidate MM-II Showed Durable Pain Relief in Global Phase 2b Study Source link

Sun Pharma - Milmet Labs merger Source link

FY20 Q2 Financial Result - Transcript Source link

Late-Breaking Phase 3 Data at AAD 2023 Show Oral Investigational Medicine Deuruxolitinib Significantly Improved Scalp Hair Regrowth in Alopecia Areata ...

Sun Pharma completes acquisition of Concert Pharmaceuticals Source link

Sun Pharma Announces US FDA Approval for Generic Lenalidomide Capsules Source link

Sun Pharma to announce third quarter results on January 31, 2022 Source link

Sun Pharma launches CEQUA™ (cyclosporine ophthalmic solution 0.09% w/v), the first dry eye treatment with nanomicellar (NCELL™) technology*, in Canada ...

Q3 FY22 Financial Press Release Source link

Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the ...

Sun Pharma to introduce its version of Vortioxetine in India under an exclusive patent license from Lundbeck Source link

Sun Pharma Announces US FDA Approval for Generic Mesalamine Extended Release Capsules Source link

Sun Pharma to announce fourth quarter results on May 30, 2022 Source link

Sun Pharma to launch Brillo®, a first-in-class oral lipid-lowering drug in India Source link

Sun Pharma Acquires Uractiv™ Portfolio from Fiterman Pharma in Romania Source link

Sun Pharma to announce first quarter results on July 29, 2022 Source link

Sun Pharma and Cosmo Announce Territory Expansion of License and Supply Agreements for WINLEVI® to include Japan, Australia, New Zealand, ...

Sun Pharma acquires Disperzyme® and Phlogam® brands to strengthen its anti-inflammatory portfolio Source link

Sun Pharma Launches SEZABY™ (phenobarbital sodium) in the U.S. for Treatment of Neonatal Seizures Source link

Sun Pharma to Acquire Concert Pharmaceuticals Inc Source link

Sun Pharma to announce third quarter results on January 31, 2023 Source link

Sun Pharma launches Palbociclib, a novel targeted therapy for advanced breast cancer with a unique Patient Assistance Program Source link

Sun Pharma is Great Place To Work® Certified™ in India Source link

SEZABY™ (phenobarbital sodium powder for injection) approved by US FDA for the treatment of neonatal seizures Source link

Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US Source link

“Apni Body Ki Suno” says the latest campaign of Sun Pharma’s Revital H Source link

Sun Pharma to announce second quarter results on November 01, 2022 Source link

Sun Pharma board to consider merger of export subsidiary Source link

Sun Pharma launches Smoquit Source link

EGM clears resolutions for split, buyback Source link

Sun Pharma H1 post results conference call on Wednesday October 22, 11am Source link

President to inaugurate Sun Pharma's research center Source link

Sun Pharma closes Able Labs acquisition in the US Source link

Sun Pharma's lead molecule enters Phase II in the US Source link

Sun Pharma announces settlement of litigation over generic Exelon® Source link

Sun Pharmaceutical extends tender offer for Taro December 19, 2008 Source link

Generic Eloxatin® and Imitrex® approval: shares 180-day marketing drug exclusivity for generic Eloxatin® Source link

Sun Pharma announces USFDA tentative approval for generic Boniva® Source link

Sun Pharma announces USFDA approval for generic Ultram® ER tablets Source link

Successful acquisition of DUSA Pharmaceuticals, Inc.U.S.A.by our subsidiary Source link

Sun Pharma announces US FDA approval for generic Cymbalta® Source link

CCI approves Ranbaxy acquisition by Sun Pharma Source link

Sun Pharma receives Warning Letter for Halol facility Source link

Sun Pharma & Moebius Medical sign deal to develop novel liposomal non-opiod pain product for osteoarthritis Source link

Sun Pharma Announces US FDA Acceptance of NDA for OTX-101 Source link

Investor Update Call Transcript Source link

FY21 Q2 Financial Press Release Source link

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India Source link